MARGARIA, JEAN PIERO
 Distribuzione geografica
Continente #
NA - Nord America 705
EU - Europa 548
AS - Asia 134
AF - Africa 8
SA - Sud America 2
Totale 1397
Nazione #
US - Stati Uniti d'America 693
IT - Italia 229
DK - Danimarca 96
CN - Cina 84
IE - Irlanda 53
SE - Svezia 37
DE - Germania 23
AT - Austria 20
UA - Ucraina 20
FR - Francia 19
GB - Regno Unito 15
CA - Canada 11
BE - Belgio 10
IN - India 8
VN - Vietnam 8
HK - Hong Kong 7
SN - Senegal 7
FI - Finlandia 6
JP - Giappone 6
KR - Corea 6
ES - Italia 4
LT - Lituania 3
PL - Polonia 3
PT - Portogallo 3
TH - Thailandia 3
TW - Taiwan 3
CH - Svizzera 2
IR - Iran 2
JO - Giordania 2
NL - Olanda 2
NO - Norvegia 2
SG - Singapore 2
TR - Turchia 2
AR - Argentina 1
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
EG - Egitto 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 1397
Città #
Chandler 174
Ann Arbor 124
Torino 103
Dublin 53
Houston 47
Beijing 35
Wilmington 30
Fairfield 25
Turin 25
Nyköping 24
Ashburn 23
Medford 20
Vienna 20
Princeton 17
Dearborn 15
Milan 15
Woodbridge 14
Boston 13
Villeurbanne 13
Jacksonville 12
Redwood City 9
Dong Ket 7
Hangzhou 7
San Diego 7
Brussels 6
Nanjing 6
Seattle 6
Boardman 5
Cambridge 5
Toronto 5
Fremont 4
Guangzhou 4
Pisa 4
Seoul 4
Chennai 3
Hefei 3
Kaunas 3
London 3
Modena 3
Mountain View 3
Munich 3
Paris 3
Shanghai 3
Trieste 3
Amman 2
Bangkok 2
Carrara 2
Central District 2
Changchun 2
Changsha 2
Faenza 2
Fort Worth 2
Guiyang 2
Hebei 2
Hyderabad 2
Kunming 2
Larvik 2
Las Vegas 2
Leuven 2
Padova 2
Rome 2
San Jose 2
Tokyo 2
Verona 2
Warsaw 2
Yinchuan 2
Anaheim 1
Auburn University 1
Averill Park 1
Baltimore 1
Belize City 1
Berlin 1
Bethesda 1
Binasco 1
Birmingham 1
Bodman-Ludwigshafen 1
Bologna 1
Bonn 1
Brest 1
Bromley 1
Buffalo 1
Cedar Knolls 1
Central 1
Chengdu 1
Des Moines 1
Duncan 1
Eindhoven 1
Frankfurt Am Main 1
Gent 1
Gostyn 1
Grafing 1
Groningen 1
Harsefeld 1
Hiroshima 1
Kaigandori 1
Kish 1
Kobe 1
Kocaeli 1
Lanzhou 1
Latina 1
Totale 989
Nome #
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 247
PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function. 237
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis 122
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 114
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF) 102
Structural determinants of Rab11 activation by the guanine nucleotide exchange factor SH3BP5 84
Class II PI3K Functions in Cell Biology and Disease 81
Rab11 activity and PtdIns(3)P turnover removes recycling cargo from endosomes 79
Phosphoinositide 3-Kinase-C2α Regulates Polycystin-2 Ciliary Entry and Protects against Kidney Cyst Formation 68
A novel multiplex qrt-pcr assay to detect sars-cov-2 infection: High sensitivity and increased testing capacity 67
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 51
Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure 43
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 39
Phosphoinositide Conversion Inactivates R-RAS and Drives Metastases in Breast Cancer 38
PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation 30
Response by Vandecasteele et al to Letter Regarding Article, âCardiac Overexpression of PDE4B Blunts Î-Adrenergic Response and Maladaptive Remodeling in Heart Failureâ 26
The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium 25
Totale 1453
Categoria #
all - tutte 2512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201887 0000 00 011 538132
2018/201977 2025 52 619 69129
2019/2020254 581216 2148 2324 28212820
2020/2021196 115105 246 3012 32201427
2021/2022377 26152241 3024 1719 24238155
2022/2023364 57512062 3998 370 0000
Totale 1453